Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study.
Ab Rahman N, Lim MT, Lee FY, Lee SC, Ramli A, Saharudin SN, King TL, Anak Jam EB, Ayub NA, Sevalingam RK, Bahari R, Ibrahim NN, Mahmud F, Sivasampu S, Peariasamy KM; SAFECOVAC study group.
Ab Rahman N, et al. Among authors: lim mt.
Vaccine. 2022 Jul 30;40(32):4394-4402. doi: 10.1016/j.vaccine.2022.05.075. Epub 2022 Jun 3.
Vaccine. 2022.
PMID: 35667917
Free PMC article.